HomeCompareSPCO vs MRK

SPCO vs MRK: Dividend Comparison 2026

SPCO yields 20.84% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $33.3K in total portfolio value· pulled ahead in Year 3
10 years
SPCO
SPCO
● Live price
20.84%
Share price
$0.19
Annual div
$0.04
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.5K
Annual income
$2.43
Full SPCO calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SPCO vs MRK

📍 MRK pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPCOMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPCO + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPCO pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPCO
Annual income on $10K today (after 15% tax)
$1,771.57/yr
After 10yr DRIP, annual income (after tax)
$2.07/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,326.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPCO + MRK for your $10,000?

SPCO: 50%MRK: 50%
100% MRK50/50100% SPCO
Portfolio after 10yr
$40.1K
Annual income
$4,900.28/yr
Blended yield
12.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SPCO
No analyst data
Altman Z
-0.1
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPCO buys
0
MRK buys
0
No recent congressional trades found for SPCO or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPCOMRK
Forward yield20.84%2.76%
Annual dividend / share$0.04$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$23.5K$56.8K
Annual income after 10y$2.43$9,798.13
Total dividends collected$2.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SPCO vs MRK ($10,000, DRIP)

YearSPCO PortfolioSPCO Income/yrMRK PortfolioMRK Income/yrGap
1$11,742$1,042.10$11,206$366.19+$536.00SPCO
2$13,136$571.80$12,650$502.35+$486.00SPCO
3← crossover$14,354$298.91$14,407$694.19$53.00MRK
4$15,512$152.63$16,585$967.82$1.1KMRK
5$16,675$77.08$19,342$1,363.89$2.7KMRK
6$17,881$38.72$22,913$1,947.19$5.0KMRK
7$19,152$19.40$27,662$2,823.89$8.5KMRK
8$20,502$9.71$34,159$4,173.35$13.7KMRK
9$21,942$4.86$43,337$6,308.80$21.4KMRK
10$23,480$2.43$56,776$9,798.13$33.3KMRK

SPCO vs MRK: Complete Analysis 2026

SPCOStock

The Stephan Co., together with its subsidiaries, manufactures, sells, and distributes hair care and personal care products. It operates in two segments, Distributors and Brands. The Distributors segment sells to distributors that purchase company's hair care products, and beauty and barber supplies for resale to salons, barbershops, and beauty schools, as well as operates as a mail order, and online barber and beauty supply company. This segment also sells products directly to cosmetology schools. The Brands segment manufacture and sells products to mass merchandisers, chain drug stores, and supermarkets that sells hair care and other personal care products directly to the end user; and distributors that sell to retailers. The company manufactures Image and Sorbie hair care products that are sold through distributors to salons; and Cashmere Bouquet talc, Quinsana Medicated talc, Balm Barr and Stretch Mark creams and lotions, Protein 29 liquid and gel grooming aids, and Stiff Stuff and Wildroot hair care products. It also markets a line of cosmetics through online and mail order channels; and manufactures and sells shampoos, hair treatments, after-shave lotion, dandruff lotion, hair conditioners, and hair spray under the brand name STEPHAN'S, as well as Lekari, New Era, OLD 97, and Imágen. In addition, it markets Hope, Interlude, and Fade-away brand names through various retail chains. The company operates in the United States, Canada, Europe, and Asia. The Stephan Co. was founded in 1897 and is headquartered in Williamsport, Pennsylvania.

Full SPCO Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SPCO vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPCO vs SCHDSPCO vs JEPISPCO vs OSPCO vs KOSPCO vs MAINSPCO vs JNJSPCO vs ABBVSPCO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.